Nikko Co., Ltd. (TYO:6306)

Orchard Therapeutics Revenue

Nikko had revenue of 8.29B JPY in the quarter ending June 30, 2025, a decrease of -15.79%. This brings the company's revenue in the last twelve months to 47.61B, up 4.63% year-over-year. In the fiscal year ending March 31, 2025, Nikko had annual revenue of 49.16B with 11.49% growth.

• Revenue (ttm): 47.61B
• Revenue Growth: +4.63%
• P/S Ratio: 0.62
• Revenue / Employee: 42.02M
• Employees: 1,133
• Market Cap: 29.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	49.16B	5.07B	11.49%
Mar 31, 2024	44.10B	4.43B	11.17%
Mar 31, 2023	39.67B	819.00M	2.11%
Mar 31, 2022	38.85B	980.00M	2.59%
Mar 31, 2021	37.87B	2.72B	7.72%